114
Views
3
CrossRef citations to date
0
Altmetric
Regular Features

Manuscript Writing

Pages 66-69 | Published online: 18 Jul 2013

References

  • Woolley KL, Barron JP. Handling manuscript rejection: insights from evidence and experience. Chest 2009;135:573–7.
  • Wyness T, McGhee C, Patel DV. Manuscript rejection in ophthalmology and visual science journals: identifying and avoiding the common pitfalls. Clin Exp Ophthalmol 2009;37:864–7.
  • Armstrong AW, Idriss SZ, Kimball AB, Bernhard JD. Fate of manuscripts declined by the Journal of the American Academy of Dermatology. J Am Acad Dermatol 2008;58:632–5.
  • Lancet Information for Authors. [cited 2011 October 7]. Available from: http://download.thelancet.com/flatcontentassets/authors/lancet-information-for-authors.pdf.
  • JAMA Instructions for Authors. [cited 2011 October 7]. Available from: http://jama.ama-assn.org/site/misc/ifora.xhtml.
  • Welcome to Resources for Authors. [cited 2011 October 7]. Available from: http://resources.bmj.com/bmj/authors.
  • Ehara S, Takahashi K. Reasons for rejection of manuscripts submitted to AJR by international authors. AJR Am J Roentgenol 2007;188:W113–6.
  • Shakiba B, Salmasian H, Yousefi-Nooraie R, Rohanizadegan M. Factors influencing editors' decision on acceptance or rejection of manuscripts: the authors' perspective. Arch Iran Med 2008;11:257–62.
  • Byrne DW. Common reasons for rejecting manuscripts at medical journals: a survey of editors and peer reviewers. Sci Ed 2000;23:39–44.
  • Northam S, Yarbrough S, Haas B, Duke G. Journal editor survey: information to help authors publish. Nurse Educ 2010;35:29–36.
  • Turcotte C, Drolet P, Girard M. Study design, originality and overall consistency influence acceptance or rejection of manuscripts submitted to the Journal. Can J Anaesth 2004;51:549–56.
  • Lee KP, Boyd EA, Holroyd-Leduc JM, Bacchetti P, Bero LA. Predictors of publication: characteristics of submitted manuscripts associated with acceptance at major biomedical journals. Med J Aust 2006;184:621–6.
  • Uniform requirements for manuscripts submitted to biomedical journals: Writing and editing for biomedical publication. [cited 2011 October 7]. Available from: http://www.icmje.org/urm_full.pdf.
  • Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med 2010;7:e1000251.
  • von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008;61:344–9.
  • Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009;62:1006–12.
  • Des Jarlais DC, Lyles C, Crepaz N. Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement. Am J Public Health 2004;94:361–6.
  • Pierson DJ. The top 10 reasons why manuscripts are not accepted for publication. Respir Care 2004;49:1246–52.
  • Leventhal PS. How do I select a target journal for a manuscript? TWS 2011;20:268–269.
  • Bernhard JD. No further studies are required: additional notes on avoiding manuscript rejection. J Am Acad Dermatol 2001;44:541–2.
  • Ohri M, Dawes K. Successful abstract writing: an essential skill for medical writers. TWS 2009;18:27–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.